Another experimental study provided evidence that the type of TP53 mutant affects the evolution of induced breast cancer: thus, p53R245W-driven breast cancers are aggressive and generate metastases at the level of lung and liver, whereas p53R172H-induced tumors are less aggressive and they require additional hits to develop metastases [340]. The gene discussed is TP53; the disease is breast carcinoma.